Abstract:Cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) (cGAMP) synthase (cGAS), along with the adaptor stimulator of interferon genes (STING), are crucial components of the innate immune system, and their study has become a research hotspot in recent years. Many biochemical and structural studies that have collectively elucidated the mechanism of activation of the cGAS-STING pathway with atomic resolution have provided insights into the roles of the cGAS-STING pathway in innate immunity and clues to the origin and evolution of the modern cGAS-STING signaling pathway. The cGAS-STING pathway has been identified to protect the host against viral infection. After detecting viral dsDNA, cGAS synthesizes a second messenger to activate STING, eliciting antiviral immune responses by promoting the expression of interferons (IFNs) and hundreds of IFN-stimulated genes (ISGs). Recently, the cGAS-STING pathway has also been found to be involved in response to bacterial infections, including bacterial pneumonia, melioidosis, tuberculosis, and sepsis. However, compared with its functions in viral infection, the cGAS-STING signaling pathway in bacterial infection is more complex and diverse since the protective and detrimental effects of type I IFN (IFN-I) on the host depend on the bacterial species and infection mode. Besides, STING activation can also affect infection prognosis through other mechanisms in different bacterial infections, independent of the IFN-I response. Interestingly, the core protein components of the mammalian cGAS-STING signaling pathway have been found in the bacterial defense system, suggesting that this widespread signaling pathway may have originated in bacteria. Here, we review recent findings related to the structures of major molecules involved in the cGAS-STING pathway and the effects of the cGAS-STING pathway in various bacterial infections and bacterial immunity, which may pave the way for the development of new antibacterial drugs that specifically kill bacteria without harmful effects on the host.

Cutibacterium acnes Infection Induces Type I Interferon Synthesis Through the cGAS-STING Pathway

cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers

Crosstalk Between Autophagy and the cGAS–STING Signaling Pathway in Type I Interferon Production

Type I IFNs facilitate innate immune control of the opportunistic bacteria Burkholderia cenocepacia in the macrophage cytosol

Short-Chain Fatty Acids from Cutibacterium acnes Activate Both a Canonical and Epigenetic Inflammatory Response in Human Sebocytes

Identification of Cgas As an Innate Immune Sensor of Extracellular Bacterium Pseudomonas Aeruginosa

Candida albicans extracellular vesicles trigger type I IFN signalling via cGAS and STING

Significance of the cGAS-STING Pathway in Health and Disease

Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease

The cGAS-STING Pathway in Bacterial Infection and Bacterial Immunity

Cgas‐sting Pathway: Post‐translational Modifications and Functions in Sterile Inflammatory Diseases

Type I interferon-dependent CCL4 is induced by a cGAS/STING pathway that bypasses viral inhibition and protects infected tissue, independent of viral burden

Intervention of Cgas‒sting Signaling in Sterile Inflammatory Diseases

<i>Staphylococcus aureus</i> Induces IFN- Production via a CARMA3-Independent Mechanism

Genetic and functional analyses of Cutibacterium acnes isolates reveal association of a linear plasmid with skin inflammation

Cgas Facilitates Sensing of Extracellular Cyclic Dinucleotides to Activate Innate Immunity

cGAS in action: Expanding roles in immunity and inflammation

A STING to inflammation and autoimmunity

Pro-inflammatory activity of Cutibacterium acnes phylotype IA1 and extracellular vesicles: An in vitro study

The cGAS–STING pathway drives type I IFN immunopathology in COVID-19

Characterization of a Cutibacterium acnes Camp Factor 1-Related Peptide as a New TLR-2 Modulator in In Vitro and Ex Vivo Models of Inflammation